Victory Capital Management Inc. Sells 627,080 Shares of ICU Medical, Inc. (NASDAQ:ICUI)

Victory Capital Management Inc. lowered its stake in shares of ICU Medical, Inc. (NASDAQ:ICUI) by 99.3% during the 4th quarter, according to its most recent filing with the SEC. The firm owned 4,592 shares of the medical instruments supplier’s stock after selling 627,080 shares during the period. Victory Capital Management Inc.’s holdings in ICU Medical were worth $458,000 as of its most recent SEC filing.

A number of other institutional investors have also recently made changes to their positions in ICUI. State of New Jersey Common Pension Fund D boosted its holdings in ICU Medical by 74.9% in the fourth quarter. State of New Jersey Common Pension Fund D now owns 29,573 shares of the medical instruments supplier’s stock worth $2,950,000 after purchasing an additional 12,660 shares during the last quarter. Yousif Capital Management LLC grew its holdings in shares of ICU Medical by 5.9% in the fourth quarter. Yousif Capital Management LLC now owns 10,129 shares of the medical instruments supplier’s stock worth $1,010,000 after acquiring an additional 560 shares during the period. Illinois Municipal Retirement Fund purchased a new stake in ICU Medical during the fourth quarter valued at $1,234,000. CWM LLC lifted its holdings in ICU Medical by 341.2% in the fourth quarter. CWM LLC now owns 578 shares of the medical instruments supplier’s stock valued at $58,000 after acquiring an additional 447 shares during the period. Finally, Federated Hermes Inc. boosted its position in ICU Medical by 39.9% in the fourth quarter. Federated Hermes Inc. now owns 176,232 shares of the medical instruments supplier’s stock worth $17,577,000 after purchasing an additional 50,265 shares during the last quarter. Hedge funds and other institutional investors own 96.10% of the company’s stock.

ICU Medical Price Performance

NASDAQ ICUI opened at $101.68 on Friday. The business’s fifty day moving average is $100.94 and its 200 day moving average is $97.41. ICU Medical, Inc. has a fifty-two week low of $78.28 and a fifty-two week high of $196.57. The company has a debt-to-equity ratio of 0.76, a quick ratio of 1.09 and a current ratio of 2.61. The company has a market capitalization of $2.48 billion, a PE ratio of -41.50 and a beta of 0.72.

ICU Medical (NASDAQ:ICUI) last posted its quarterly earnings data on Tuesday, February 27th. The medical instruments supplier reported $1.24 earnings per share for the quarter, beating analysts’ consensus estimates of $0.85 by $0.39. The firm had revenue of $587.86 million for the quarter, compared to analysts’ expectations of $564.77 million. ICU Medical had a positive return on equity of 5.38% and a negative net margin of 2.63%. Sell-side analysts predict that ICU Medical, Inc. will post 3.5 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Separately, KeyCorp increased their price objective on shares of ICU Medical from $134.00 to $136.00 and gave the stock an “overweight” rating in a research note on Wednesday, February 28th.

Insider Transactions at ICU Medical

In related news, Director Elisha W. Finney sold 300 shares of the company’s stock in a transaction on Thursday, May 16th. The shares were sold at an average price of $104.95, for a total value of $31,485.00. Following the completion of the transaction, the director now owns 2,129 shares of the company’s stock, valued at approximately $223,438.55. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. In related news, Director Elisha W. Finney sold 300 shares of the business’s stock in a transaction that occurred on Thursday, May 16th. The stock was sold at an average price of $104.95, for a total value of $31,485.00. Following the transaction, the director now directly owns 2,129 shares of the company’s stock, valued at approximately $223,438.55. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, Director George A. Lopez sold 1,890 shares of the company’s stock in a transaction that occurred on Monday, March 11th. The stock was sold at an average price of $104.22, for a total value of $196,975.80. Following the completion of the transaction, the director now owns 317,753 shares of the company’s stock, valued at $33,116,217.66. The disclosure for this sale can be found here. Insiders sold a total of 26,562 shares of company stock valued at $2,788,117 over the last three months. Corporate insiders own 6.70% of the company’s stock.

ICU Medical Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.